Compare Frontline Plc Ordinary Shares (FRO) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Frontline Plc Ordinary Shares vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Frontline Plc Ordinary Shares trades at $56.37 (market cap $12.52B), while Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B). The key difference: Frontline Plc Ordinary Shares is far larger — about 7.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Frontline Plc Ordinary Shares pays a 9.56% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Frontline Plc Ordinary Shares for 0 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| FRO | NUVB | |
|---|---|---|
Market Cap | $12.52B | $1.74B |
Volume | 6,375,509 | 9,289,619 |
Sector | Industrials | Health |
52-Week High | $56.26 | $9.54 |
52-Week Low | $20.58 | $3.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.64B | $1.33B |
Dividend Yield | 9.56% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Frontline Plc Ordinary Shares
Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.
Read more on FRO →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
